Abstract
(Molecular Therapy - Nucleic Acids 3, e159; April 29, 2014) Main TextIn the originally published version of this article, the number of cells used in the xenograft model was indicated incorrectly. In the section “Xenograft experiments using nude mice,” 7 × 105 A549 lung cancer cells were utilized, not 7 × 107 as indicated. The authors apologize for the error and any confusion that may have resulted.
| Original language | English |
|---|---|
| Pages (from-to) | 493 |
| Number of pages | 1 |
| Journal | Molecular Therapy Nucleic Acids |
| Volume | 8 |
| DOIs |
|
| State | Published - 15 Sep 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery
Fingerprint
Dive into the research topics of 'Erratum: Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo (Molecular Therapy - Nucleic Acids (2014) 3 (S2162253116303006) (10.1038/mtna.2014.9))'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver